Delivery Order SPE2DB24D1021-SPE2DB25FEZSJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections valued at $5,624.52 with a completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,088.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections with a contract ceiling value of $47,883.19. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by August 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $11,387.60. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is set to be completed by September 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections with a ceiling value of $1,738.43. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, indicating it was open to all qualified vendors in federal competition. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,904.63. This competitively awarded, firm fixed-price delivery order is set to be completed by July 18, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $4,140.74. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with a ceiling value of $5,226.06 under a firm fixed price contract. This delivery order is classified as a child contract, indicating it was issued under a larger indefinite delivery vehicle. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with a ceiling value of $1,904.63 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZSJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally. The Mounjaro delivery represents a routine pharmaceutical supply fulfillment supporting the Defense Health Agency and other federal healthcare systems' ongoing medication requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/15/25 |